Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-06

AUTHORS

Shigemitsu Inada, Tsuyoshi Koto, Kitaro Futami, Sumitaka Arima, Akinori Iwashita

ABSTRACT

The subjects in this study consisted of 40 preoperative untreated esophageal squamous cell carcinoma patients. While p53 did not significantly correlate with the clinicopathological factors, E-cadherin significantly correlated with lymphatic invasion, vascular invasion, the depth of invasion, the degree of lymph node metastasis, the histological stage, and the number of lymph node metastases. Epidermal growth factor receptor (EGFR) significantly correlated with age, the depth of invasion, and the number of lymph node metastases. The 5-year cumulative survival rate was 45.7% in the p53-positive cases and 61.9% in the p53-negative cases, with no significant difference, and 87.8% in the E-cadherinpositive cases and 19.1% in the-negative cases, and the difference was significnat. The prognosis was significantly poor in EGFR-positive subjects: the 5-year survival rate was 38.6% in EGFR-positive cases and 68% in-negative cases. The 5-year survival rate in E-cadherin-negative, EGFR-positive cases was 0%, while it was 91.7% in the reverse pattern, and this difference was significant. These findings suggest that both E-cadherin and EGFR are important prognostic factors, and a more precise prognosis can thus be obtained by combining them. Such a combined technique may be very useful as an indicator for grading the biological malignancy of esophageal cancer. More... »

PAGES

493-503

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02482343

DOI

http://dx.doi.org/10.1007/bf02482343

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046003256

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10385363


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cadherins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ErbB Receptors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Esophageal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymph Nodes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoid Tissue", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413918.6", 
          "name": [
            "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
            "Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inada", 
        "givenName": "Shigemitsu", 
        "id": "sg:person.011721713455.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011721713455.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413918.6", 
          "name": [
            "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koto", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.01203522244.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203522244.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413918.6", 
          "name": [
            "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Futami", 
        "givenName": "Kitaro", 
        "id": "sg:person.0673552367.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673552367.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413918.6", 
          "name": [
            "Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arima", 
        "givenName": "Sumitaka", 
        "id": "sg:person.01101441153.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101441153.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413918.6", 
          "name": [
            "Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iwashita", 
        "givenName": "Akinori", 
        "id": "sg:person.0623221337.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623221337.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01608335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021087568", 
          "https://doi.org/10.1007/bf01608335"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/342705a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041126170", 
          "https://doi.org/10.1038/342705a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-06", 
    "datePublishedReg": "1999-06-01", 
    "description": "The subjects in this study consisted of 40 preoperative untreated esophageal squamous cell carcinoma patients. While p53 did not significantly correlate with the clinicopathological factors, E-cadherin significantly correlated with lymphatic invasion, vascular invasion, the depth of invasion, the degree of lymph node metastasis, the histological stage, and the number of lymph node metastases. Epidermal growth factor receptor (EGFR) significantly correlated with age, the depth of invasion, and the number of lymph node metastases. The 5-year cumulative survival rate was 45.7% in the p53-positive cases and 61.9% in the p53-negative cases, with no significant difference, and 87.8% in the E-cadherinpositive cases and 19.1% in the-negative cases, and the difference was significnat. The prognosis was significantly poor in EGFR-positive subjects: the 5-year survival rate was 38.6% in EGFR-positive cases and 68% in-negative cases. The 5-year survival rate in E-cadherin-negative, EGFR-positive cases was 0%, while it was 91.7% in the reverse pattern, and this difference was significant. These findings suggest that both E-cadherin and EGFR are important prognostic factors, and a more precise prognosis can thus be obtained by combining them. Such a combined technique may be very useful as an indicator for grading the biological malignancy of esophageal cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02482343", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102161", 
        "issn": [
          "0941-1291", 
          "1436-2813"
        ], 
        "name": "Surgery Today", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "keywords": [
      "epidermal growth factor receptor", 
      "number of lymph", 
      "depth of invasion", 
      "EGFR-positive cases", 
      "survival rate", 
      "esophageal cancer", 
      "esophageal squamous cell carcinoma patients", 
      "squamous cell carcinoma patients", 
      "negative cases", 
      "cumulative survival rate", 
      "important prognostic factor", 
      "lymph node metastasis", 
      "p53-negative cases", 
      "p53-positive cases", 
      "evaluation of malignancy", 
      "growth factor receptor", 
      "prognostic factors", 
      "carcinoma patients", 
      "clinicopathological factors", 
      "node metastasis", 
      "vascular invasion", 
      "biological malignancy", 
      "lymphatic invasion", 
      "immunohistochemical study", 
      "histological stage", 
      "prognosis", 
      "precise prognosis", 
      "metastasis", 
      "factor receptor", 
      "lymph", 
      "significant differences", 
      "malignancy", 
      "cancer", 
      "invasion", 
      "subjects", 
      "cadherin", 
      "patients", 
      "cases", 
      "reverse pattern", 
      "differences", 
      "combined technique", 
      "receptors", 
      "significnat", 
      "age", 
      "factors", 
      "rate", 
      "p53", 
      "study", 
      "findings", 
      "evaluation", 
      "number", 
      "stage", 
      "indicators", 
      "patterns", 
      "degree", 
      "technique", 
      "depth"
    ], 
    "name": "Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)", 
    "pagination": "493-503", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046003256"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02482343"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10385363"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02482343", 
      "https://app.dimensions.ai/details/publication/pub.1046003256"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T09:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_323.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02482343"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02482343'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02482343'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02482343'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02482343'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      22 PREDICATES      105 URIs      95 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02482343 schema:about N0a2495043dda4fa4aa90af1124b5e7d5
2 N26d37c8316f94013987f337e6dbac64c
3 N4b87869b694c47eeb688bac7a6087ff3
4 N516983a09b374ca4a3c12a88ba38ed81
5 N58adf29391de4843b5831d3fe5b71463
6 N6c17d43a593b4966ac7c4977adf8573c
7 N78e9c3846c52433ab4e56d27dd1828bb
8 N7cc254b28fd34152afba3b6d580f2a81
9 N7f85c1f93a5f48889c377490eefed782
10 N80d0fdc903f04bbfb21c0d8f57c513ee
11 N840a4109ef8f4f60a2fc5b261f830415
12 N8804b9bf74324c5bbe632462a887d601
13 N999af79714ea4ead9a19c1ac4fdee07a
14 Na11adfe8eb17475480cb39fc493a9982
15 Nb5d4c4f00967480ea69e6e556ba5a87f
16 Nda73b7cb0a82487592b1b07e602c4205
17 Ndf879d4c72ad453b98dd093dc6e3117c
18 Ne339457d52b24f01bf4745eb19109115
19 Nee9714fefed64a58a20857993cbd3a56
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N4552ed809d6d4052b8964c13884f81eb
23 schema:citation sg:pub.10.1007/bf01608335
24 sg:pub.10.1038/342705a0
25 schema:datePublished 1999-06
26 schema:datePublishedReg 1999-06-01
27 schema:description The subjects in this study consisted of 40 preoperative untreated esophageal squamous cell carcinoma patients. While p53 did not significantly correlate with the clinicopathological factors, E-cadherin significantly correlated with lymphatic invasion, vascular invasion, the depth of invasion, the degree of lymph node metastasis, the histological stage, and the number of lymph node metastases. Epidermal growth factor receptor (EGFR) significantly correlated with age, the depth of invasion, and the number of lymph node metastases. The 5-year cumulative survival rate was 45.7% in the p53-positive cases and 61.9% in the p53-negative cases, with no significant difference, and 87.8% in the E-cadherinpositive cases and 19.1% in the-negative cases, and the difference was significnat. The prognosis was significantly poor in EGFR-positive subjects: the 5-year survival rate was 38.6% in EGFR-positive cases and 68% in-negative cases. The 5-year survival rate in E-cadherin-negative, EGFR-positive cases was 0%, while it was 91.7% in the reverse pattern, and this difference was significant. These findings suggest that both E-cadherin and EGFR are important prognostic factors, and a more precise prognosis can thus be obtained by combining them. Such a combined technique may be very useful as an indicator for grading the biological malignancy of esophageal cancer.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N113cc9caf2264833b5ca2bd5c941671e
32 Nb87191be449841d28bcf666673f78ba5
33 sg:journal.1102161
34 schema:keywords EGFR-positive cases
35 age
36 biological malignancy
37 cadherin
38 cancer
39 carcinoma patients
40 cases
41 clinicopathological factors
42 combined technique
43 cumulative survival rate
44 degree
45 depth
46 depth of invasion
47 differences
48 epidermal growth factor receptor
49 esophageal cancer
50 esophageal squamous cell carcinoma patients
51 evaluation
52 evaluation of malignancy
53 factor receptor
54 factors
55 findings
56 growth factor receptor
57 histological stage
58 immunohistochemical study
59 important prognostic factor
60 indicators
61 invasion
62 lymph
63 lymph node metastasis
64 lymphatic invasion
65 malignancy
66 metastasis
67 negative cases
68 node metastasis
69 number
70 number of lymph
71 p53
72 p53-negative cases
73 p53-positive cases
74 patients
75 patterns
76 precise prognosis
77 prognosis
78 prognostic factors
79 rate
80 receptors
81 reverse pattern
82 significant differences
83 significnat
84 squamous cell carcinoma patients
85 stage
86 study
87 subjects
88 survival rate
89 technique
90 vascular invasion
91 schema:name Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)
92 schema:pagination 493-503
93 schema:productId N3c5e03d2a0f2402cabd81939034dfe00
94 N3ddf9ac807f2406abced902454b0ecc6
95 N6e6fec81a0824acca61b5b8886b556eb
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046003256
97 https://doi.org/10.1007/bf02482343
98 schema:sdDatePublished 2022-05-10T09:51
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Nfa4ae39e050a491d84bc62498ccea757
101 schema:url https://doi.org/10.1007/bf02482343
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N08b1e8c02e444f3bb9d4819db255f975 rdf:first sg:person.01101441153.40
106 rdf:rest N2dc8ea3bdd664a22b7c797cea5792c61
107 N0a2495043dda4fa4aa90af1124b5e7d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Middle Aged
109 rdf:type schema:DefinedTerm
110 N113cc9caf2264833b5ca2bd5c941671e schema:volumeNumber 29
111 rdf:type schema:PublicationVolume
112 N26d37c8316f94013987f337e6dbac64c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Esophageal Neoplasms
114 rdf:type schema:DefinedTerm
115 N2dc8ea3bdd664a22b7c797cea5792c61 rdf:first sg:person.0623221337.30
116 rdf:rest rdf:nil
117 N3573d0b59ff3470d85b5f17c99a12822 rdf:first sg:person.01203522244.46
118 rdf:rest N37c9c6a092d74d368e9afebf391d3d4b
119 N37c9c6a092d74d368e9afebf391d3d4b rdf:first sg:person.0673552367.46
120 rdf:rest N08b1e8c02e444f3bb9d4819db255f975
121 N3c5e03d2a0f2402cabd81939034dfe00 schema:name pubmed_id
122 schema:value 10385363
123 rdf:type schema:PropertyValue
124 N3ddf9ac807f2406abced902454b0ecc6 schema:name dimensions_id
125 schema:value pub.1046003256
126 rdf:type schema:PropertyValue
127 N4552ed809d6d4052b8964c13884f81eb rdf:first sg:person.011721713455.25
128 rdf:rest N3573d0b59ff3470d85b5f17c99a12822
129 N4b87869b694c47eeb688bac7a6087ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged
131 rdf:type schema:DefinedTerm
132 N516983a09b374ca4a3c12a88ba38ed81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Lymphatic Metastasis
134 rdf:type schema:DefinedTerm
135 N58adf29391de4843b5831d3fe5b71463 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Male
137 rdf:type schema:DefinedTerm
138 N6c17d43a593b4966ac7c4977adf8573c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Carcinoma, Squamous Cell
140 rdf:type schema:DefinedTerm
141 N6e6fec81a0824acca61b5b8886b556eb schema:name doi
142 schema:value 10.1007/bf02482343
143 rdf:type schema:PropertyValue
144 N78e9c3846c52433ab4e56d27dd1828bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Lymph Nodes
146 rdf:type schema:DefinedTerm
147 N7cc254b28fd34152afba3b6d580f2a81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name ErbB Receptors
149 rdf:type schema:DefinedTerm
150 N7f85c1f93a5f48889c377490eefed782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Biomarkers, Tumor
152 rdf:type schema:DefinedTerm
153 N80d0fdc903f04bbfb21c0d8f57c513ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cadherins
155 rdf:type schema:DefinedTerm
156 N840a4109ef8f4f60a2fc5b261f830415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 N8804b9bf74324c5bbe632462a887d601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Tumor Suppressor Protein p53
161 rdf:type schema:DefinedTerm
162 N999af79714ea4ead9a19c1ac4fdee07a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Survival Rate
164 rdf:type schema:DefinedTerm
165 Na11adfe8eb17475480cb39fc493a9982 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Adult
167 rdf:type schema:DefinedTerm
168 Nb5d4c4f00967480ea69e6e556ba5a87f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Female
170 rdf:type schema:DefinedTerm
171 Nb87191be449841d28bcf666673f78ba5 schema:issueNumber 6
172 rdf:type schema:PublicationIssue
173 Nda73b7cb0a82487592b1b07e602c4205 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Prognosis
175 rdf:type schema:DefinedTerm
176 Ndf879d4c72ad453b98dd093dc6e3117c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Lymphoid Tissue
178 rdf:type schema:DefinedTerm
179 Ne339457d52b24f01bf4745eb19109115 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Immunohistochemistry
181 rdf:type schema:DefinedTerm
182 Nee9714fefed64a58a20857993cbd3a56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Neoplasm Invasiveness
184 rdf:type schema:DefinedTerm
185 Nfa4ae39e050a491d84bc62498ccea757 schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
188 schema:name Medical and Health Sciences
189 rdf:type schema:DefinedTerm
190 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
191 schema:name Oncology and Carcinogenesis
192 rdf:type schema:DefinedTerm
193 sg:journal.1102161 schema:issn 0941-1291
194 1436-2813
195 schema:name Surgery Today
196 schema:publisher Springer Nature
197 rdf:type schema:Periodical
198 sg:person.01101441153.40 schema:affiliation grid-institutes:grid.413918.6
199 schema:familyName Arima
200 schema:givenName Sumitaka
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101441153.40
202 rdf:type schema:Person
203 sg:person.011721713455.25 schema:affiliation grid-institutes:grid.413918.6
204 schema:familyName Inada
205 schema:givenName Shigemitsu
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011721713455.25
207 rdf:type schema:Person
208 sg:person.01203522244.46 schema:affiliation grid-institutes:grid.413918.6
209 schema:familyName Koto
210 schema:givenName Tsuyoshi
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203522244.46
212 rdf:type schema:Person
213 sg:person.0623221337.30 schema:affiliation grid-institutes:grid.413918.6
214 schema:familyName Iwashita
215 schema:givenName Akinori
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623221337.30
217 rdf:type schema:Person
218 sg:person.0673552367.46 schema:affiliation grid-institutes:grid.413918.6
219 schema:familyName Futami
220 schema:givenName Kitaro
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673552367.46
222 rdf:type schema:Person
223 sg:pub.10.1007/bf01608335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021087568
224 https://doi.org/10.1007/bf01608335
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/342705a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041126170
227 https://doi.org/10.1038/342705a0
228 rdf:type schema:CreativeWork
229 grid-institutes:grid.413918.6 schema:alternateName Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan
230 Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan
231 schema:name Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan
232 Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...